Identification of Proteins that Regulate Radiation-induced Apoptosis in Murine Tumors with Wild Type p53

  • SEONG Jinsil
    Department of Radiation Oncology, Yonsei University Medical College Brain Korea 21 Project for Medical Science, Yonsei University Medical College Institute for Gastroenterology, Yonsei University Medical College
  • OH Hae Jin
    Department of Radiation Oncology, Yonsei University Medical College Brain Korea 21 Project for Medical Science, Yonsei University Medical College
  • KIM Jiyoung
    Department of Radiation Oncology, Yonsei University Medical College Brain Korea 21 Project for Medical Science, Yonsei University Medical College
  • AN Jeung Hee
    Department of Radiation Oncology, Yonsei University Medical College Brain Korea 21 Project for Medical Science, Yonsei University Medical College
  • KIM Wonwoo
    Department of Radiation Oncology, Yonsei University Medical College Brain Korea 21 Project for Medical Science, Yonsei University Medical College

この論文をさがす

抄録

In this study, we investigated the molecular factors determining the induction of apoptosis by radiation. Two murine tumors syngeneic to C3H/HeJ mice were used: an ovarian carcinoma OCa-I, and a hepatocarcinoma HCa-I. Both have wild type p53, but display distinctly different radiosensitivity in terms of specific growth delay (12.7 d in OCa-I and 0.3 d in HCa-I) and tumor cure dose 50% (52.6 Gy in OCa-I and > 80 Gy in HCa-I). Eight-mm tumors on the thighs of mice were irradiated with 25 Gy and tumor samples were collected at regular time intervals after irradiation. The peak levels of apoptosis were 16.1 ± 0.6% in OCa-I and 0.2 ± 0.0% in HCa-I at 4 h after radiation, and this time point was used for subsequent proteomics analysis. Protein spots were identified by peptide mass fingerprinting with a focus on those related to apoptosis. In OCa-I tumors, radiation increased the expression of cytochrome c oxidase and Bcl2/adenovirus E1B-interacting 2 (Nip 2) protein higher than 3-fold. However in HCa-I, these two proteins showed no significant change.<br> The results suggest that radiosensitivity in tumors with wild type p53 is regulated by a complex mechanism. Furthermore, these proteins could be molecular targets for a novel therapeutic strategy involving the regulation of radiosensitivity.<br>

収録刊行物

参考文献 (43)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ